NCT04008849View on ClinicalTrials.gov

A Follow-up Study in Patients With Inherited Metabolic Disorders (IMD) Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) With MGTA-456

TerminatedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

May 21, 2019

Primary Completion Date

October 8, 2020

Study Completion Date

October 8, 2020

Conditions
Inherited Metabolic Disorders (IMD)
Interventions
OTHER

Safety and efficacy assessments

Long term safety and clinical outcomes

Trial Locations (1)

55455

University of Minnesota, Minneapolis

Sponsors
All Listed Sponsors
lead

Magenta Therapeutics, Inc.

INDUSTRY